SurgiMab
Phase 1SurgiMab is a clinical-stage biotechnology company at the forefront of real-time cancer detection.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
SurgiMab is a clinical-stage biotechnology company at the forefront of real-time cancer detection.
Diagnostics